Yestar Healthcare Holdings Company Limited
HKEX:2393.HK
0.051 (HKD) • At close September 20, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) HKD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 2,912.733 | 4,293.982 | 4,930.692 | 4,106.938 | 4,903.268 | 4,446.954 | 3,926.877 | 3,021.831 | 2,454.684 | 1,531.353 | 1,173.334 | 955.818 |
| Cost of Revenue
| 2,399.951 | 3,585.273 | 4,081.997 | 3,300.058 | 3,637.961 | 3,248.123 | 2,821.057 | 2,255.498 | 1,937.276 | 1,267.888 | 963.899 | 788.508 |
| Gross Profit
| 512.782 | 708.709 | 848.695 | 806.88 | 1,265.307 | 1,198.831 | 1,105.82 | 766.333 | 517.408 | 263.465 | 209.435 | 167.31 |
| Gross Profit Ratio
| 0.176 | 0.165 | 0.172 | 0.196 | 0.258 | 0.27 | 0.282 | 0.254 | 0.211 | 0.172 | 0.178 | 0.175 |
| Reseach & Development Expenses
| 35.735 | 21.151 | 1.242 | 0.648 | 0.463 | 0.357 | 0.593 | 1.058 | 3.434 | 1.988 | 1.567 | 0 |
| General & Administrative Expenses
| 264.221 | 336.104 | 320.665 | 336.763 | 357.145 | 316.861 | 285.805 | 226.649 | 141.875 | 58.673 | 62.947 | 41.101 |
| Selling & Marketing Expenses
| 116.357 | 308.115 | 336.343 | 286.699 | 296.962 | 231.658 | 174.564 | 116.807 | 83.36 | 57.005 | 52.43 | 49.638 |
| SG&A
| 380.578 | 786.223 | 664.329 | 648.741 | 654.107 | 548.519 | 460.369 | 343.456 | 225.235 | 115.678 | 115.377 | 90.739 |
| Other Expenses
| -4.18 | -786.361 | -16.957 | -801.906 | -47.47 | -22.793 | -17.024 | -6.954 | -6.965 | -5.54 | -1.478 | -0.007 |
| Operating Expenses
| 369.194 | 1,523.055 | 669.21 | 1,386.746 | 687.095 | 567.691 | 457.389 | 329.859 | 221.599 | 115.027 | 111.692 | 86.427 |
| Operating Income
| 171.041 | -77.514 | 184.366 | 158.139 | 611.2 | 650.312 | 645.451 | 422.877 | 292.173 | 147.787 | 94.058 | 82.864 |
| Operating Income Ratio
| 0.059 | -0.018 | 0.037 | 0.039 | 0.125 | 0.146 | 0.164 | 0.14 | 0.119 | 0.097 | 0.08 | 0.087 |
| Total Other Income Expenses Net
| -130.001 | -1,029.828 | -124.424 | -850.734 | -160.307 | -140.625 | -115.533 | -39.072 | -12.247 | -0.739 | -0.392 | -1.291 |
| Income Before Tax
| 41.04 | -1,107.342 | 59.942 | -692.595 | 450.893 | 509.687 | 529.918 | 383.805 | 279.926 | 147.048 | 93.666 | 81.573 |
| Income Before Tax Ratio
| 0.014 | -0.258 | 0.012 | -0.169 | 0.092 | 0.115 | 0.135 | 0.127 | 0.114 | 0.096 | 0.08 | 0.085 |
| Income Tax Expense
| 39.562 | 86.748 | 47.263 | 47.297 | 149.639 | 160.152 | 179.343 | 113.877 | 81.413 | 43.502 | 28.331 | 23.54 |
| Net Income
| -13.888 | -992.232 | 3.327 | -590.485 | 202.673 | 251.746 | 249.968 | 201.031 | 162.756 | 100.9 | 65.072 | 56.517 |
| Net Income Ratio
| -0.005 | -0.231 | 0.001 | -0.144 | 0.041 | 0.057 | 0.064 | 0.067 | 0.066 | 0.066 | 0.055 | 0.059 |
| EPS
| -0.006 | -0.43 | 0.001 | -0.25 | 0.085 | 0.12 | 0.11 | 0.092 | 0.081 | 0.054 | 0.045 | 0.03 |
| EPS Diluted
| -0.006 | -0.43 | 0.001 | -0.25 | 0.085 | 0.12 | 0.11 | 0.092 | 0.081 | 0.054 | 0.045 | 0.03 |
| EBITDA
| 312.855 | 44.021 | 315.887 | 305.489 | 766.383 | 802.427 | 783.621 | 514.756 | 349.596 | 164.609 | 106.643 | 94.322 |
| EBITDA Ratio
| 0.107 | 0.01 | 0.064 | 0.074 | 0.156 | 0.18 | 0.2 | 0.17 | 0.142 | 0.107 | 0.091 | 0.099 |